Arrakis Therapeutics

Arrakis, Roche sign $190M RNA-targeting platform technology deal

The deal will involve using Arrakis' RNA-targeted small molecule platform technology to discover potential drugs in the research and development areas on which the Swiss drugmaker focuses.

By Alaric DeArment

BioPharma, Startups

Arrakis spices up development efforts with $75M Series B round for RNA-targeting drugs

The company has raised more than $100 million since 2017 and plans to use the current funding to build a pipeline of RNA-targeting small molecules.

By Alaric DeArment

Health IT

Reducing Clinical and Staff Burnout with AI Automation

As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.

By Dr. Michael Blackman, Chief Medical Officer at Greenway Health

Consumer / Employer

Health Executives on Digital Transformation in Healthcare

Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.

By MedCity News